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Background: Congenital diaphragmatic hernia (CDH) is a structural birth defect associated
with pulmonary hypoplasia and pulmonary arterial hypertension (PAH). We hypothesize
that echocardiography provides a method to assess real-time right ventricle (RV) function,
remodeling, and pulmonary artery (PA) flow.
Materials and methods: Slit3 wild-type (WT) (n ¼ 6) and knockout (KO) (n ¼ 5) mice were
analyzed at 2-3 months of age. Mice were anesthetized using isoflurane. Echocardiography
was performed to analyze left and right ventricular wall thickness, internal diameter (ID),
and function. Color Doppler was used to analyze flow in the PA and across the tricuspid
valve.
Results: There was significant RV dilation in the KO mice versus WT, with an average RVID
of 1.99 mm versus 1.26 mm, respectively (P ¼ 0.007). Flow in the PA of KO mice was altered
compared to WT, with elevated PA velocity time indices, 30.68 mm versus 22.13 mm
(P ¼ 0.012), elevated PA peak velocities, 952.61 mm/s versus 628.73 mm/s (P ¼ 0.003), and
decreased pulmonary acceleration times, 8.94 ms versus 16.18 ms (P ¼ 0.002), respectively.
Pulmonary vascular resistance, calculated by measuring tricuspid regurgitation peak ve-
locity and right ventricular outflow tract velocity time index, was increased in KO versus
WT mice, 17.61 mm2/s versus 8.91 mm2/s (P ¼ 0.003), respectively.
Conclusions: Slit3 KO mice with CDH show evidence of PAH and resultant RV dilation. Using
direct cardiac puncture, elevated RV systolic pressures have been demonstrated in KOmice
as evidence of PAH. Echocardiography allows direct analysis of the PA and real-time RV
function without sacrifice of the mouse. This mode of evaluation allows longitudinal study
in mice with PAH and CDH.
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pulmonary hypoplasia that affectsmost CDHpatients. Studies
have shown that more severe PAH is associated with worse
survival.2 No therapy exists for PAH in CDH because the
mechanisms leading to the development of PAH in CDH have
yet to be determined. Thus, CDH patients are managed with
ventilator strategies and pharmacologic measures that are
only supportive in nature.
Slit3 is part of the Slit family of genes with a number of
functions, including axonal guidance, angiogenesis, axon
attraction and repulsion, and cell chemotaxis. It is expressed
in the mesothelium of the diaphragm during embryonic
development. Slit3 knockout (KO) mice have been found to
develop a diaphragmatic hernia at birth similar to the central
(septum transversum) CDH in humans.3 Previous studies in
humans with CDH have shown pathologic changes in the
pulmonary arteries and veins, known as pulmonary vascular
remodeling, that lead to the development of PAH.4 The Slit3
KOmouse is a uniquemousemodel for CDH because themice
are viable, which provides the unique opportunity to measure
for changes consistent with PAH in vivo.
Current methods to evaluate PAH in mouse models
include right heart catheterization and measurement of the
right ventricular systolic pressure (RVSP), which in the
absence of pulmonary stenosis allows for an estimation of
PAH.5 However, right heart catheterization is a terminal
procedure in mice, which precludes longitudinal study.
Furthermore, right heart catheterization is difficult in Slit3
KO mice with CDH that often have distorted thoracic anat-
omy as a result of the diaphragmatic hernia. Therefore,
assessment of RVSP by direct cardiac puncture has been
performed in our laboratory to estimate PAH. However, this
too results in sacrifice of the mouse. The aforementioned
limitations result in an inability to serially assess PAH in
mouse models and prevent the longitudinal assessment of
mice with PAH before and after potential treatment mo-
dalities, inhibiting the investigation of the mechanisms
leading to the development of PAH in CDH.
In humans, although right heart catheterization is required
to confirm the diagnosis of PAH, echocardiography is a
commonly used screening test, and the only noninvasive
technique to follow the course of the disease.6 Furthermore,
studies have shown that echocardiography can successfully
assess pulmonary hypertension in rat and mouse models in a
noninvasive manner.7,8 We hypothesize that transthoracic
echocardiography provides a method to assess real-time right
ventricle (RV) function, remodeling, and pulmonary artery
(PA) flow in the Slit3 KO mouse model for CDH.Methods
Slit3 WT and KO mice were bred and housed at our institu-
tional animal facility under Institutional Animal Care and Use
Committee protocol. Six WT and five KO mice were analyzed
at 2-3months (adult) of age, of which sixmice weremales and
five mice were females. To perform transthoracic echocardi-
ography, the mice were lightly anesthetized using isoflurane
anesthesia. Inhaled isoflurane was administered at 3%induction and 1%-1.5%maintenance. Once anesthetized, each
mouse was placed in the supine position on a temperature-
controlled mouse pad. Isoflurane was administered with a
goal heart rate of 450-500 beats per minute. The mouse was
restrained by taping all four limbs to the temperature-
controlled mouse pad. A depilatory agent was then applied
to the anterior chest to remove any hair. The mice were
observed continuously while anesthetized and restrained
during the echocardiography procedure. Clinical signs of
deterioration included a dramatic slowing of heart rate less
than 400 bpm, abnormal breathing patterns, or absent
response to toe-pinch, any of which resulted in reduction of
the isoflurane anesthesia.
Cardiac function was analyzed via echocardiography using
the VisualSonics Vevo 2100 ultrasound machine (FUJIFILM
VisualSonics, Inc, Toronto, Ontario, Canada). Aquasonic Gel
(Parker Laboratories, Inc, Fairfield, NJ), kept in a gel heater, was
applied to the anterior chest. The transducer probe (40 MHz,
VisualSonics Model MS550D) was applied to the anterior chest
first in a parasternal long axis view, with an approximately 30
angle counterclockwise, left of the parasternal line with the
transducer notch pointing caudally8 (Fig. 1A). In this position,
using the Bmode setting of the ultrasoundmachine, a full view
of the left ventricle (LV) in the parasternal long axis view can be
obtained (Fig. 2). Once the left ventricle is clearly visualized, the
ultrasound can be switched to Mmode, the mode representing
the movement of structures over time, with the indicator line
positioned to go through the widest portion of the LV chamber,
using the aorta as a landmark. This view can saved via cine
store on the ultrasound machine to be used to perform off-line
calculations of heart rate, LV anterior and posterior wall
thickness, LV internal diameter, LV ejection fraction, and LV
fractional shortening (Fig. 2).
Next, the parasternal short axis view is obtained. The ul-
trasound is placed back in Bmode, and the transducer probe is
rotated 90 clockwise from the parasternal long axis view, to
obtain the parasternal short axis view (Fig. 1B). The probe can
be tilted gently toward the cranium to obtain a cross-sectional
view of the heart at the level of the aortic valve. In this view,
the right atrium can be seen, separated from the RV by the
tricuspid valve (Fig. 3). Once this view is obtained, the ultra-
sound can be switched to the color Doppler mode. The pulse
wave (PW)-line of the ultrasound, the line placed in the di-
rection of flow, can be placed over the tricuspid valve to
measure flow through the tricuspid valve. This can be used for
off-line calculations of pulmonary vascular resistance (PVR),
using the equation,
PVR ¼ TRmax velocity

VTIRVOT
where TRmax velocity is the maximum velocity of tricuspid
regurgitation (Fig. 4), divided by the velocity time integral of
the right ventricular outflow tract, VTIRVOT.
9
A modified parasternal long axis view can be obtained to
visualize blood flow through the PA. Beginning in the para-
sternal long axis view position, in B mode of the ultrasound,
the probe can be gently rotated clockwise, until the probe is
parallel to the sternum on the left hemithorax of the mouse.
The probe can then gently be tilted laterally to obtain a view of
the PA crossing over the aorta. Once this view is obtained in B
A B
Fig. 1 e Illustration of probe positioning. Gray line indicates probe position to obtain the (A) parasternal long axis view and
(B) parasternal short axis view.
s h ah e t a l  e c h o c a r d i o g r a p h y i n m i c e w i t h c dh 37mode, the ultrasound can be switched to the color Doppler
mode. The PW line of the ultrasound can be placed along the
PA, parallel to the direction of blood flow in the vessel, to
obtain a flow waveform (Fig. 5). This can be repeated for flow
across the pulmonary valve and for the flow through the right
ventricular outflow tract. These views can be saved via cine
store on the ultrasound and can be used to perform off-line
calculations of PA velocity time index, PA peak flow velocity
(Fig. 6), pulmonary valve velocity time index, and right ven-
tricular outflow tract velocity time index. Mean pulmonary
arterial pressure (MPAP) cannot be accurately calculated in the
mouse using the Vevo 2100 ultrasound; therefore, the PA ac-
celeration time (PAT) was used as an estimate of MPAP.10 The
MPAP equation used in the Vevo 2100 ultrasound is based on
human clinical equations, where the PAT is much higher than
in the mouse, generally greater than 120 ms, due to the much
lower human heart rate compared to the mouse. Therefore,
the equation is inaccurate when applied to mice. PAT is used
instead as an estimate ofMPAP and is calculated bymeasuring
the time between the initiation of the pulmonary arterial
waveform and the pulmonary arterial peak velocity (Fig. 6)
and is known to decrease as pulmonary arterial pressure in-
creases5 and has been shown to inversely and linearly corre-
late with MPAP in humans.11,12Fig. 2 e (Left) Parasternal long axis view of the left ventricle in Bm
valve, PA[ pulmonary artery, LV[ left ventricle, LVPW[ left v
the left ventricle in M mode. In the thumbnail above, the yellow
widest portion of the LV chamber at the level of the aorta. In th
diameter (LVID) can be performed at diastole (D) and at systole (
and posterior wall (LVPW) dimensions can also be calculated at
version of figure is available online.)Finally, the last view to be obtained is a modified para-
sternal short axis view. A similar angle is used to the para-
sternal short axis view (Fig. 1B); however, the probe is placed
at the lateral aspect of the mid-right hemithorax to obtain a
cross-sectional view of the heart with the RV anterior to the
left ventricle (Fig. 7). Once this view is obtained in the B
mode of the ultrasound, the ultrasound can be switched to
M mode. The indicator line is then placed such that it
transects the widest portion of the RV chamber. This view
can be saved via cine store on the ultrasound to perform off-
line calculations of RV anterior wall thickness, RV internal
diameter (ID)eat diastole and at systole (Fig. 7), and RV
fractional shortening (FS). RV FS is calculated using the
equation,




where the RV end diastolic dimension is calculated as the
RVID at diastole, and the RV end systolic dimension is calcu-
lated as RVID at systole.13
To validate the echocardiographic findings, after echo-
cardiography was performed, the RVSP of three WT and
three KO mice was obtained by direct cardiac puncture. All
mice were allowed to fully recover from the anesthesiaode. LVAW[ Left ventricle anterior wall, PV[ pulmonary
entricle posterior wall. (Right) Parasternal long axis view of
dashed line represents the indicator line positioned at the
e M mode view below, measurements of the LV internal
S), represented by the white lines. The LV anterior (LVAW)
diastole and systole, represented by the gray lines. (Color
Fig. 3 e Parasternal short axis view at the level of the aortic valve. TV [ tricuspid valve; RV [ right ventricle;
PV[ pulmonary valve; AV[ aortic valve; PA[ pulmonary artery; RA[ right atrium; and LA[ left atrium. (Color version of
figure is available online.)
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anesthesia was induced via the drop method, and
then maintained via nose cone at 1%-2% isoflurane. Each
mouse was placed on a temperature-controlled mouse pad,
and all four limbs were restrained with tape. A 25-5/8 gauge
needle attached to a pressure transducer was then inserted
into the RV transdiaphragmatically. A right ventricular
waveform was obtained and analyzed using LabChart6
software.
Off-line data analysis was performed using Vevo 2100
software. Statistical analysis was performed using t-test with
Microsoft Excel. Male and femalemicewere used in this study,
and the gender of themouse was not considered to be a factor
in the statistical analysis of the data. Echocardiography and
off-line data analysis was performed by a single observer. The
observer was blinded to the genotype of themouse during off-
line data analysis. This study was approved by the University
of North Carolina Institutional Animal Care and Use
Committee.Fig. 4 e Tricuspid regurgitation maximum velocity, calculated f
tricuspid valve. (Color version of figure is available online.)Results
WT and KO mice were approximately the same weight on
average, 28.5 versus 28.8 kg, respectively (P ¼ 0.93). Mean heart
rate was similar in both groups, 470.49 versus 503.39 beats per
minute (bpm), in WT versus KO mice respectively (P ¼ 0.54).
Left ventricular dimension and function was similar in WT
versus KO mice, with LVAW (diastole) thickness of 0.82 versus
0.69 mm (P ¼ 0.07), LVID (diastole) of 3.53 versus 3.46 mm
(P ¼ 0.84), LVPW (diastole) thickness of 0.96 versus 0.83 mm
(P ¼ 0.29), LV EF of 60.39 versus 58.66% (P ¼ 0.87), and LV FS of
34.03 versus 30.75% (P ¼ 0.71). For the aforementioned results
please see Table 1.
Right ventricular functionwas similar inWT versusKOmice,
with RV FS of 39.19 versus 52.38% (P¼ 0.19) and right ventricular
outflow tract (RVOT) VTI of 21.37 versus 17.30 mm (P ¼ 0.15).
However, the RV dimensions were significantly different in the
two groups with a higher RVID (diastole) in KOmice comparedrom the color Doppler waveform of flow through the
Fig. 5 e (Left) Modified parasternal long axis view demonstrating the right ventricular outflow tract and pulmonary artery in
B mode of the ultrasound. (Right) Same view in color Doppler mode, used to assess flow through the pulmonary artery. The
PW line is seen along the pulmonary artery on the right, positioned parallel to the direction of blood flow in the vessel, and
can also be positioned to assess flow across the pulmonary valve and right ventricular outflow tract. RV [ right ventricle;
RVOT [ right ventricular outflow tract; PA [ pulmonary artery; LV [ left ventricle; IVS [ interventricular septum;
Ao [ aorta; and LA [ left atrium. (Color version of figure is available online.)
s h ah e t a l  e c h o c a r d i o g r a p h y i n m i c e w i t h c dh 39to WT, 1.98 versus 1.26 mm, respectively (P ¼ 0.007). RVAW
(diastole) thickness was similar in both groups, 0.503 versus
0.500 mm in WT versus KO respectively (P ¼ 0.97) (Table 1).
Flow through the PA was significantly altered in KO mice
when compared to WT mice. The PA peak velocity was
elevated in KO mice versus WT, 952.61 versus 628.73 mm/s,
respectively (P ¼ 0.003). PA VTI was also elevated in KO mice
versus WT, 30.68 versus 22.13 mm, respectively (P ¼ 0.012).
PAT was decreased in KO mice versus WT, 8.94 versus
16.18 ms, respectively (P ¼ 0.002), which suggests an esti-
mated increased MPAP for KO compared to WT mice.
Furthermore, pulmonary vascular resistance was increased
in KO mice versus WT, 17.61 versus 8.91 mm2/s, respectively
(P ¼ 0.003) (Table 1).Fig. 6 e Color Doppler image of flow through the pulmonary ar
time (PAT), measured as the time elapsed between the beginni
velocity time integral (VTI), and PA peak velocity. (Color versionTo validate these echocardiographic findings, RVSP was
calculated via direct cardiac puncture. The RVSP was signifi-
cantly elevated in KOmice compared toWTmice, 35.39 3.41
versus 16.01  1.70 mmHg, respectively (P ¼ 0.0009; Fig. 8).Discussion
In this study, we are able to demonstrate that transthoracic
echocardiography can accurately and reproducibly charac-
terize PAH and resultant RV remodeling in Slit3 KO mice with
CDH and PAH. Thus, we are able to assess PAH in a noninva-
sive manner that does not require sacrifice of the mouse.
Before this method, studies of PAH relied largely ontery (PA), used to calculate pulmonary arterial acceleration
ng of the waveform to the point of PA peak velocity, PA
of figure is available online.)
Fig. 7 e (Left) Modified parasternal short axis view in B mode visualizing the heart in cross section. The right ventricle is
seen anterior to the left ventricle. (Right) Modified parasternal short axis view of the right ventricle in M mode. In the
thumbnail above, the yellow dashed line represents the indicator line positioned at the widest portion of the RV chamber. In
the M mode view below, measurements of the RV internal diameter (RVID) and RV anterior (RVAW) dimension can be
calculated. RVAW [ right ventricle anterior wall; RV [ right ventricle; IVS [ interventricular septum; LV [ left ventricle.
(Color version of figure is available online.)
40 j o u rn a l o f s u r g i c a l r e s e a r c h  j a n u a r y 2 0 1 8 ( 2 2 1 ) 3 5e4 2estimation of PAH by obtaining RVSP measurement via right
heart catheterization or direct cardiac puncture, both ofwhich
are nonsurvivable procedures. We also demonstrate the abil-
ity to validate our echocardiographic results with RVSP mea-
surements obtained by direct cardiac puncture.Table 1 e Echocardiographic measurements and RVSP
calculated by direct cardiac puncture in WT and KOmice.
Measurements WT (n ¼ 6) KO (n ¼ 5) P value
Weight (kg) 28.47 28.76 0.93
Heart rate (bpm) 470.49 503.39 0.54
LVAW diastole (mm) 0.82 0.69 0.07
LVID diastole (mm) 3.53 3.46 0.84
LVPW diastole (mm) 0.96 0.83 0.29
LV EF (%) 60.39 58.67 0.87
LV FS (%) 34.03 30.75 0.71
RV FS (%) 39.19 51.38 0.19
RVOT VTI (mm) 21.37 17.30 0.15
RVID diastole (mm) 1.26 1.99 0.007
RVAW diastole (mm) 0.503 0.500 0.97
PA peak velocity (mm/s) 628.73 952.61 0.0028
PA VTI (mm) 22.13 30.68 0.012
PAT (ms) 16.18 8.94 0.002
PVR (mm2/s) 8.91 17.61 0.03
RVSP (mmHg) 16.01
WT (n ¼ 3)
35.39
KO (n ¼ 3)
0.0009
Bpm ¼ beats per minute; LVAW ¼ left ventricle anterior wall;
LVID ¼ left ventricle internal diameter; LVPW ¼ left ventricle pos-
terior wall; LV EF ¼ left ventricle ejection fraction; LV FS ¼ left
ventricle fractional shortening; RVOT VTI ¼ right ventricular
outflow tract velocity time index; RVID ¼ right ventricle internal
diameter; RVAW ¼ right ventricle anterior wall; PA
VTI ¼ pulmonary artery velocity time index; PAT ¼ pulmonary ar-
tery acceleration time; PVR ¼ pulmonary vascular resistance.Slit3 KO mice do not exhibit changes in LV structure or
function, with similar LVAW, LVPW, and LVID dimensions
and LV EF and LV FS measurements to WT mice. Therefore,
the presence of CDH does not appear to affect the left side of
the heart in Slit3 KO mice, which is understandable given the
knowledge that Slit3 KO mice with CDH develop central or
right sided diaphragmatic hernias. Furthermore, although
there is RV remodeling in Slit3 KO mice, with RV dilation, the
RV function seems to be preserved, with similar RVOT VTI and
RV FS measurements in KO and WT mice. The preserved RV
function may account for the viability of the KOmice. Finally,
we are able to demonstrate altered PA flow in a number of
different ways, including significant differences in PA VTI, PA
peak velocity, PAT, and PVR in KO compared to WT mice.
These findings were validated by demonstrating elevated
RVSP by direct cardiac puncture in the KO compared to WT
mice.
Taken together, these echocardiographic techniques allow
for a comprehensive assessment of PA flow and RV remodel-
ing. PVR is able to be indirectly calculated, but PA flow is ableFig. 8 e Right ventricular systolic pressure measured via
direct cardiac puncture. RV systolic pressure is
significantly elevated in KO compared to WT mice. *RV
systolic pressure elevated in KO versus WT (P< 0.0001).
s h ah e t a l  e c h o c a r d i o g r a p h y i n m i c e w i t h c dh 41to be directly assessed by measuring PA VTI and PA peak ve-
locity. Furthermore, although we were unable to accurately
calculate MPAP, we were able to provide an estimate of MPAP
by calculating PAT. Also, we were able to document the effect
of ongoing PAH on the RV, by visualizing significant RV
dilation.
As this noninvasive technique does not require sacrifice of
the mouse, it provides a novel manner to longitudinally
monitor the development of PAH in Slit3 KO mice with CDH.
As we simultaneously work to understand the mechanisms
driving the pulmonary vascular remodeling that causes PAH
in CDH, echocardiography allows a method through which
mice can be assessed over time to track the progression of
PAH, and if possible, potentially monitor for reversal of PAH
with appropriate treatment. Currently, there is limited in-
formation in the literature in general regarding right heart
evaluation by echocardiography in the mouse, which
through this study we demonstrate is indeed possible.
Furthermore, the techniques described in this study can be
used in a wider scope to investigate all murine models for
pulmonary hypertension, further adding to the significance
of this study.
A limitation to this method is that the mice required
anesthesia. Fortunately, we have been able to limit the total
procedural time to 10-15 min, minimizing the exposure of the
mice to the anesthetic. We were also able to successfully
anesthetize the mice with a low level of inhaled isoflurane,
which has minimal cardiac side effects.14 The mice were also
continuouslymonitored for evaluation of heart rate, breathing
pattern, and response to toe-pinch, to assure that the mice
were not deeply anesthetized. The heart rate in both groups of
mice, WT and KO, were similar, suggesting an equivalent
anesthetic effect that should not impede on echocardio-
graphic measurements.Conclusion
CDH is a relatively common congenital disorder with
morbidity and mortality due to associated pulmonary hypo-
plasia and PAH. The Slit3 KO mouse model is a reliable model
with which to study PAH in the context of CDH. Transthoracic
echocardiography reliably and accurately is able to assess
altered pulmonary arterial flow and resultant right ventricular
remodeling in the Slit3 mouse model for CDH. This noninva-
sive method of assessment does not require sacrifice of the
mouse and allows for a uniquemethod to longitudinally study
PAH in the context of CDH.
Acknowledgment
The authors would like to thank Dr Jennifer Whitham and Dr
Scott Buck for their guidance in echocardiographic technique.
The authors would also like to thank Dr. James Faber for
technical assistance and overall guidance. They also would
also like to greatly thank Maria Gambarian for her assistance
in the care of the mice used in this study. This research was
conducted under the aid of the UNC T32 Training Grant (grantnumber T32GM008450) and the Robert Wood Johnson Harold
Amos Faculty Development Program (67069).
Authors’ contribution: M.S. (Mansi.Shah@unchealth.unc.
edu) and S.E.M. (sean_mclean@med.unc.edu) contributed for
conception, design, experimentation, analysis and interpre-
tation, and writing of the manuscript. M.R.P., (miphilli@unch.
unc.edu) M.Q., (Megan.Quintana@unchealth.unc.edu), and
G.S. (gary_stupp@med.unc.edu) contributed for experimenta-
tion and revision of the manuscript.
Disclosure
The authors report no proprietary or commercial interest in
any product mentioned or concept discussed in this article.r e f e r e n c e s
1. Wynn J, Krishnan U, Aspelund G, et al. Outcomes of
congenital diaphragmatic hernia in the modern
era of management. J Pediatr. 2013;163:
114e119.e1.
2. Dillon PW, Cilley RE, Mauger D, Zachary C, Meier A. The
relationship of pulmonary artery pressure and survival in
congenital diaphragmatic hernia. J Pediatr Surg.
2004;39:307e312. discussion 307-312.
3. Yuan W, Rao Y, Babiuk RP, Greer JJ, Wu JY, Ornitz DM. A
genetic model for a central (septum transversum) congenital
diaphragmatic hernia in mice lacking Slit3. Proc Natl Acad Sci
U S A. 2003;100:5217e5222.
4. Taira Y, Yamataka T, Miyazaki E, Puri P. Adventitial changes
in pulmonary vasculature in congenital diaphragmatic hernia
complicated by pulmonary hypertension. J Pediatr Surg.
1998;33:382e387.
5. Thibault HB, Kurtz B, Raher MJ, et al. Noninvasive assessment
of murine pulmonary arterial pressure: validation and
application to models of pulmonary hypertension. Circ
Cardiovasc Imaging. 2010;3:157e163.
6. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009
expert consensus document on pulmonary hypertension: a
report of the American College of Cardiology Foundation Task
Force on Expert Consensus Documents and the American
Heart Association: developed in collaboration with the
American College of Chest Physicians, American Thoracic
Society, Inc., and the Pulmonary Hypertension Association.
Circulation. 2009;119:2250e2294.
7. Jones JE, Mendes L, Rudd MA, Russo G, Loscalzo J, Zhang YY.
Serial noninvasive assessment of progressive pulmonary
hypertension in a rat model. Am J Physiol Heart Circ Physiol.
2002;283:H364eH371.
8. Cheng HW, Fisch S, Cheng S, et al. Assessment of right
ventricular structure and function in mouse model of
pulmonary artery constriction by transthoracic
echocardiography. J Vis Exp. 2014:e51041.
9. Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA,
Lester SJ. A simple method for noninvasive estimation of
pulmonary vascular resistance. J Am Coll Cardiol.
2003;41:1021e1027.
10. Granstam SO, Bjo¨rklund E, Wikstro¨m G, Roos MW. Use of
echocardiographic pulmonary acceleration time and estimated
vascular resistance for the evaluation of possible pulmonary
hypertension. Cardiovasc Ultrasound. 2013;11:7.
11. Martin-Duran R, Larman M, Trugeda A, et al. Comparison of
Doppler-determined elevated pulmonary arterial pressure
42 j o u rn a l o f s u r g i c a l r e s e a r c h  j a n u a r y 2 0 1 8 ( 2 2 1 ) 3 5e4 2with pressure measured at cardiac catheterization. Am J
Cardiol. 1986;57:859e863.
12. Kitabatake A, Inoue M, Asao M, et al. Noninvasive evaluation
of pulmonary hypertension by a pulsed Doppler technique.
Circulation. 1983;68:302e309.13. VisualSonics Inc.. VisualSonics Vevo 2100 imaging system
operator manual. Toronto: VisualSonics Inc; 2001-2008.
14. Constantinides C, Mean R, Janssen BJ. Effects of isoflurane
anesthesia on the cardiovascular function of the C57BL/6
mouse. ILAR J. 2011;52:e21ee31.
